BioSpace News Archive

The National Electrical Manufacturers Association published NEMA SPD 1.1-2019 Part 1—Surge Protective Device Specification Guide for Low-Voltage Power Distribution Systems.

At the U.S. Food and Drug Administration, increasing our scientific knowledge and capabilities is a cornerstone to ensuring the safety of the foods that Americans consume.

GasLab.com has launched its new ecommerce portal allowing global customers to search and purchase a variety of sensors and accessories.

EmCyte, is proud to announce that it has received FDA 510(k) clearance for its PureBMC® Supraphysiologic Concentrating System.

The University of Mount Union is proud to announce that its Physical Therapy program has received accreditation from the Commission on Accreditation in Physical Therapy Education.

The Lupus Research Alliance is pleased to share positive topline results from a Phase 2 clinical study of a potential new treatment for proliferative lupus nephritis, the most severe form of kidney damage caused by lupus.

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled “Oral Semaglutide—The PIONEER Program Trials” today at the American Diabetes Association’s® (ADA) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco.

Combination of growth, inflation, and risks move panelists’ consensus toward Fed easing

“Such intriguing questions go to the heart of how we think about the value of individual human beings,” says John G. West, a co-creator of the new Science Uprising video series from Discovery Institute.

The University of Chicago Medicine’s Comprehensive Hypertension Center is participating in an FDA-approved pivotal trial of a novel catheter-based, non-surgical procedure to treat patients with drug-resistant hypertension.